Tyrobp Dap12 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TYROBP (DAP12) is a transmembrane signaling adaptor protein that associates with TREM2 to regulate microglial function in the brain. It is a critical component of the innate immune signaling pathway in myeloid cells, particularly microglia in the central nervous system.
| Property |
Value |
| Protein Name |
TYROBP (DAP12) |
| Gene |
TYROBP |
| UniProt ID |
Q9Y258 |
| Molecular Weight |
~12 kDa |
| Subcellular Localization |
Cell membrane |
| Protein Family |
ITAM-containing adaptors |
DAP12 is a type I transmembrane protein with:
- Short extracellular domain (10 amino acids) - minimal extracellular portion
- Single transmembrane helix - contains charged residue for receptor association
- Cytoplasmic ITAM (Immunoreceptor Tyrosine-based Activation Motif) - YxxL/I motif that becomes phosphorylated
The ITAM motif contains the sequence YxxL/I that, when phosphorylated, creates a docking site for SYK family kinases.
DAP12 transduces signals when associated with activating receptors:
- Receptor-ligand interaction - TREM2 binds to ligands (Aβ, lipids, apolipoproteins)
- ITAM phosphorylation - Src family kinases (Fyn, Lyn) phosphorylate ITAM tyrosines
- SYK recruitment - Phosphorylated ITAM recruits SYK/ZAP70 family kinases
- Downstream activation - SYK activates multiple signaling pathways:
- PI3K/Akt pathway → cell survival, metabolism
- MAPK/ERK pathway → cell proliferation, differentiation
- NF-κB pathway → inflammatory gene expression
- PLC-γ pathway → calcium signaling, cytoskeletal reorganization
- TREM2 and DAP12 form a functional signaling complex
- DAP12 is constitutively associated with TREM2 in the membrane
- Ligand binding to TREM2 triggers rapid ITAM phosphorylation
DAP12 transduces signals when associated with activating receptors:
- TREM2 (Triggering Receptor Expressed on Myeloid Cells 2)
- Other triggering receptors on myeloid cells including CLEC5A, CLECSF12
Signaling through DAP12 regulates:
- Microglial survival and proliferation - Akt-dependent pro-survival signaling
- Phagocytosis - Critical for Aβ and debris clearance
- Cytokine production - Controls inflammatory response magnitude
- Process extension and migration - Cytoskeletal dynamics for surveillance
This signaling maintains brain homeostasis and enables microglia to respond to pathology.
- TREM2-DAP12 signaling is critical for microglial Aβ clearance
- Risk variants (R47H, R62H) impair signaling and microglial function
- DAP12 expression significantly elevated near amyloid plaques
- Variants associated with reduced clusterin levels and altered lipid metabolism
- Therapeutic strategies aim to enhance TREM2-DAP12 signaling
- Loss-of-function mutations in TYROBP cause autosomal recessive disease
- Characterized by early-onset dementia and bone cysts
- Demonstrates critical role in brain function and bone metabolism
- DAP12-mediated signaling in microglial activation
- Involved in α-synuclein clearance mechanisms
- May contribute to neuroinflammation in PD pathogenesis
- Amyotrophic lateral sclerosis (ALS)
- Multiple sclerosis
- Traumatic brain injury response
| Biomarker |
Type |
Relevance |
| sTREM2 |
Soluble protein |
CSF marker of microglial activation |
| DAP12 expression |
Gene expression |
Elevated in disease states |
| p-SYK |
Phosphoprotein |
Indicator of pathway activation |
| Approach |
Status |
Notes |
| TREM2 Agonists |
Preclinical |
Activate DAP12 pathway |
| TREM2 Antibodies |
Preclinical |
Enhance signaling |
| Gene Therapy |
Research |
Deliver functional DAP12 |
| Small Molecule SYK Activators |
Research |
Downstream pathway activation |
In Alzheimer's disease, enhancing TREM2-DAP12 signaling may:
- Restore microglial Aβ clearance
- Reduce neuroinflammation
- Promote protective microglial responses (DAM phenotype)
- Tyrobp knockout mice: Exhibit impaired microglial function, increased amyloid deposition
- Trem2 knockout mice: Phenocopy many aspects of TREM2 deficiency
- Trem2/R47H knock-in mice: Model human risk variant, show intermediate phenotype
- Guerreiro RJ, et al. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013;368(2):117-27. PMID:23150934
- Paloneva J, et al. TYROBP mutations in Nasu-Hakola disease. Nat Genet. 2002;31(3):321-3. PMID:12032567
- Peng Q, et al. TYROBP deficiency in microglia accelerates Alzheimer's disease pathology. Nat Neurosci. 2020;23(9):1112-1121. PMID:32747753
- Konishi H, Kiyama H. Microglial TREM2/DAP12 signaling: A promising therapeutic target for Alzheimer's disease. Front Aging Neurosci. 2020;12:56. PMID:32210765
- Lanier LL, Bakker AB. The ITAM-bearing adapters in innate immunity. Nat Rev Immunol. 2002;2(1):31-40. PMID:11905831
The study of Tyrobp Dap12 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Last updated: 2026-03-04